Johansson Johanna M, Du Rietz Hampus, Hedlund Hampus, Eriksson Hanna C, Oude Blenke Erik, Pote Aditya, Harun Said, Nordenfelt Pontus, Lindfors Lennart, Wittrup Anders
Lund University, Department of Clinical Sciences Lund, Section for Oncology, Lund, Sweden.
Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Nat Commun. 2025 Jul 1;16(1):5354. doi: 10.1038/s41467-025-60959-z.
Lipid nanoparticles (LNPs) are clinically approved for mRNA-based vaccines and liver-targeted siRNA delivery. However, poor nucleic acid delivery efficiency limits their application in extrahepatic tissues and tumors. Here, using live-cell and super-resolution microscopy, we identify multiple distinct steps of inefficiencies in the cytosolic delivery of both siRNA and mRNA cargoes. Membrane damages marked by galectin recruitment are conducive to cytosolic RNA release, whereas membrane perturbations recruiting the ESCRT machinery do not permit endosomal escape. Notably, only a small fraction of RNA is released from galectin-marked endosomes and, unexpectedly, many damaged endosomes contain no detectable RNA cargo. Using LNPs with both fluorescently labeled ionizable lipid and RNA, we show that these components segregate during endosomal sorting - both within single endosomes and across endosomal compartments. Finally, we visualize localized ionizable lipid enrichment in endosomal membranes and membrane damage in direct proximity to siRNA-LNPs tethered to luminal vesicle membranes. Taken together, our findings reveal multiple mechanistic barriers limiting intracellular RNA delivery by LNPs.
脂质纳米颗粒(LNPs)已在临床上获批用于基于mRNA的疫苗和肝脏靶向性siRNA递送。然而,核酸递送效率低下限制了它们在肝外组织和肿瘤中的应用。在此,我们利用活细胞和超分辨率显微镜,确定了siRNA和mRNA货物胞质递送过程中多个不同的低效步骤。由半乳糖凝集素募集标记的膜损伤有利于胞质RNA释放,而募集ESCRT机制的膜扰动则不允许内体逃逸。值得注意的是,只有一小部分RNA从半乳糖凝集素标记的内体中释放出来,而且出乎意料的是,许多受损内体中没有可检测到的RNA货物。使用同时带有荧光标记的可电离脂质和RNA的LNPs,我们表明这些成分在内体分选过程中会分离——无论是在单个内体中还是在内体隔室之间。最后,我们观察到内体膜中可电离脂质的局部富集以及与附着在腔内囊泡膜上的siRNA-LNPs直接相邻的膜损伤。综上所述,我们的研究结果揭示了限制LNPs细胞内RNA递送的多个机制性障碍。